Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.

Παρόμοια τεκμήρια

• Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
  ανά: Nicola Gianotti, κ.ά.
  Έκδοση: (2017-01-01)
• Timeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patients.
  ανά: Mathieu Bastard, κ.ά.
  Έκδοση: (2012-01-01)
• Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
  ανά: Fidler, S, κ.ά.
  Έκδοση: (2002)
• Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
  ανά: Fidler, S, κ.ά.
  Έκδοση: (2002)
• HIV multi‐drug resistance at first‐line antiretroviral failure and subsequent virological response in Asia
  ανά: Awachana Jiamsakul, κ.ά.
  Έκδοση: (2014-01-01)